Literature DB >> 22460579

Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98.

Hang Thi Thu Nguyen1, Didier Merlin.   

Abstract

The transmembrane glycoprotein CD98 is a potential regulator of multiple functions, including integrin signaling and amino acid transport. Abnormal expression or function of CD98 and disruption of the interactions between CD98 and its binding partners result in defects in cell homeostasis and immune responses. Indeed, expression of CD98 has been correlated with diseases such as inflammation and tumor metastasis. Modulation of CD98 expression and/or function therefore represents a promising therapeutic strategy for the treatment and prevention of such pathologies. Herein, we review the role of CD98 with focus on its functional importance in homeostasis and immune responses, which could help to better understand the pathogenesis of CD98-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460579      PMCID: PMC4402973          DOI: 10.1007/s00018-012-0963-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  103 in total

1.  Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  S Schreiber; R P MacDermott; A Raedler; R Pinnau; M J Bertovich; G S Nash
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

2.  Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids.

Authors:  Y Fukasawa; H Segawa; J Y Kim; A Chairoungdua; D K Kim; H Matsuo; S H Cha; H Endou; Y Kanai
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

3.  Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation.

Authors:  Torsten Kucharzik; Andreas Lugering; Yutao Yan; Adel Driss; Laetitia Charrier; Shanthi Sitaraman; Didier Merlin
Journal:  Lab Invest       Date:  2005-07       Impact factor: 5.662

4.  CD98-mediated links between amino acid transport and beta 1 integrin distribution in polarized columnar epithelia.

Authors:  D Merlin; S Sitaraman; X Liu; K Eastburn; J Sun; T Kucharzik; B Lewis; J L Madara
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

5.  Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98.

Authors:  K Hara; H Kudoh; T Enomoto; Y Hashimoto; T Masuko
Journal:  Biochem Biophys Res Commun       Date:  1999-09-07       Impact factor: 3.575

6.  Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Hisao Imai; Kimihiro Shimizu; Noriko Yanagitani; Noriaki Sunaga; Takeshi Hisada; Tamotsu Ishizuka; Yoshikatsu Kanai; Takashi Nakajima; Masatomo Mori
Journal:  Lung Cancer       Date:  2009-01-26       Impact factor: 5.705

7.  CD98hc facilitates B cell proliferation and adaptive humoral immunity.

Authors:  Joseph Cantor; Cecille D Browne; Raphael Ruppert; Chloé C Féral; Reinhard Fässler; Robert C Rickert; Mark H Ginsberg
Journal:  Nat Immunol       Date:  2009-03-08       Impact factor: 25.606

8.  Extracellular domain of CD98hc is required for early murine development.

Authors:  Yukiyasu Sato; Rachel A Heimeier; Cuiling Li; Chuxia Deng; Yun-Bo Shi
Journal:  Cell Biosci       Date:  2011-02-25       Impact factor: 7.133

9.  Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture.

Authors:  A Moretta; M C Mingari; B F Haynes; R P Sekaly; L Moretta; A S Fauci
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

10.  Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).

Authors:  Per Fogelstrand; Chloé C Féral; Ramin Zargham; Mark H Ginsberg
Journal:  J Exp Med       Date:  2009-10-19       Impact factor: 14.307

View more
  14 in total

1.  Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.

Authors:  Bo Xiao; Hamed Laroui; Emilie Viennois; Saravanan Ayyadurai; Moiz A Charania; Yuchen Zhang; Zhan Zhang; Mark T Baker; Benyue Zhang; Andrew T Gewirtz; Didier Merlin
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

2.  Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.

Authors:  Bo Xiao; Panpan Ma; Emilie Viennois; Didier Merlin
Journal:  Colloids Surf B Biointerfaces       Date:  2016-03-14       Impact factor: 5.268

Review 3.  Clathrin-independent endocytosis: a cargo-centric view.

Authors:  Lymarie Maldonado-Báez; Chad Williamson; Julie G Donaldson
Journal:  Exp Cell Res       Date:  2013-08-13       Impact factor: 3.905

4.  A chemical synthesis of a multiply 13 C-labeled hexasaccharide: a high-mannose N-glycan fragment.

Authors:  Wenhui Zhang; Qingfeng Pan; Anthony S Serianni
Journal:  J Labelled Comp Radiopharm       Date:  2016-07-08       Impact factor: 1.921

Review 5.  Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Authors:  Yonghyun Lee; Nobuhiko Kamada; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2021-10-26       Impact factor: 15.470

Review 6.  Role of microRNAs in the immune system, inflammation and cancer.

Authors:  Jennifer Raisch; Arlette Darfeuille-Michaud; Hang Thi Thu Nguyen
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

7.  Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature.

Authors:  Jean-David Morel; Anja O Paatero; Jiajie Wei; Jonathan W Yewdell; Laure Guenin-Macé; Delphi Van Haver; Francis Impens; Natalia Pietrosemoli; Ville O Paavilainen; Caroline Demangel
Journal:  Mol Cell Proteomics       Date:  2018-06-18       Impact factor: 5.911

8.  Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer.

Authors:  Cuilan Li; Vincent W S Liu; Pui Man Chiu; Kwok-Ming Yao; Hextan Y S Ngan; David W Chan
Journal:  Mol Cancer       Date:  2014-03-06       Impact factor: 27.401

9.  Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.

Authors:  Bo Xiao; Zhan Zhang; Emilie Viennois; Yuejun Kang; Mingzhen Zhang; Moon Kwon Han; Jiucun Chen; Didier Merlin
Journal:  Theranostics       Date:  2016-09-25       Impact factor: 11.556

10.  A global live cell barcoding approach for multiplexed mass cytometry profiling of mouse tumors.

Authors:  Soren Charmsaz; Nicole Gross; Elizabeth Jaffee; Won Jin Ho
Journal:  JCI Insight       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.